Coats' disease at Shields stage 1 (retinal telangiectasia only) or stage 2 (telangiectasia with exudation), when active disease progression is documented, requires prompt, targeted intervention to prevent advancement to more severe stages.

Clinical Scenario

This protocol addresses early-stage Coats' disease with demonstrated progression. At stage 1, the retina shows telangiectatic vessel changes without exudation. At stage 2, exudation is present alongside the telangiectasia. Both stages remain amenable to intervention directed at the abnormal vasculature before vision-threatening complications arise.

Treatment Approach (Partial Summary)

The primary treatment targets the abnormal retinal vasculature directly. Laser photocoagulation is the established first-line approach at these early stages — the specific technique, retreatment strategy, and how many sessions may be needed are detailed in the full protocol.

Clinical goal: Ablation and regression of the abnormal retinal vasculature, with preservation of vision and prevention of disease progression.

References

DOI: 10.1159/000336906

For years, the main treatment options have been laser photocoagulation and cryotherapy, especially for mild or moderate stages of the disease.
In 92% of cases, laser photocoagulation was used as primary treatment and cryotherapy as second line.
Laser photocoagulation is utilized to cauterize retinal vasculature and can be used in mild disease with limited exudation, corresponding to stages 1, 2 and 3a according to Shields' classification.
The overall aim of treatment in mild disease is ablation of the abnormal retinal vasculature, preservation of vision and prevention of disease progressing to retinal detachment.

View source ↗

Treatment of Coats' Disease at Shields Stage 1 or Stage 2 with Disease Progression

References